Preclinical Safety Evaluation of Pharmaceutical Products

Xiaoya  Zhang

doi:10.4172/2167-065X.1000226

ISSN: 2167-065X

Clinical Pharmacology & Biopharmaceutics
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Commentary
Clin Pharmacol Biopharm 2021, Vol 10(6): 226
DOI: 10.4172/2167-065X.1000226

Preclinical Safety Evaluation of Pharmaceutical Products

Xiaoya Zhang: Department of Pharmacology and Systems Therapeutics, Mount Sinai School of Medicine, United States

^*Corresponding Author :

Received Date: Jun 12, 2021 / Accepted Date: Jun 22, 2021 / Published Date: Jul 29, 2021

View PDF Download PDF

Citation: Zhang X (2021) Preclinical Safety Evaluation of Pharmaceutical Products. Clin Pharmacol Biopharm, 10: 226 Doi: 10.4172/2167-065X.1000226

Copyright: © 2021 Zhang X. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.